Teva Pharmaceutical Industries Limited (TEVA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Core Insights - Teva Pharmaceuticals had a significant year in 2025, marked by substantial financial achievements and advancements in its pipeline [2]. Group 1 - Richard Francis serves as the President and CEO of Teva Pharmaceuticals, with Eli Kalif, Chris Stevo, and Sanjeev Sharma representing the Investor Relations team [1]. - The presentation is part of a conference hosted by Barclays Bank, indicating a focus on investor engagement and communication [1][3].